H. Jean Khoury
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Eosinophilic Disorders and Syndromes, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research
Most-Cited Works
- → A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias(2013)1,111 cited
- → Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial(2018)576 cited
- → Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia(2008)487 cited
- → European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia(2016)470 cited
- → Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib(2011)458 cited
- → BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia(2014)364 cited
- → Glutamate Dehydrogenase 1 Signals through Antioxidant Glutathione Peroxidase 1 to Regulate Redox Homeostasis and Tumor Growth(2015)356 cited
- → Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure(2012)315 cited
- → Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex(2014)299 cited
- → 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1–AMPK signalling(2015)280 cited